FDA Expands Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy

June 20, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a

Stay Connected

Find us on socials